Client login Menu Home / Analytical & Solid State Services / formufast™: Pre-Clinical Formulation Development Analytical & Solid State Services Pharmaceutical Method Development and Validation Pharmaceutical Drug Product Release Testing Stability Testing and Storage of Pharmaceutical Products Solid State Services Solid State Services Solid State Analysis Preformulation Preformulation Pre-Clinical Package for Small Molecules formufast™: Pre-Clinical Formulation Development Mass Spectrometry Biologics Testing Bioanalysis / Pharmacokinetics Analytical Laboratory Testing Facilities Contact Us formufast™: Pre-Clinical Formulation Development Often drug candidates can exhibit poor bioavailability in early animal studies, which cannot always be overcome by traditional salt formation or particle size reduction strategies. Developing a strong understanding early in drug development is key to preventing common reasons for failure and producing enabling formulations to maximise outcomes. Our early formulation platform, formufastTM is an intelligent approach that identifies potential challenges and creates rational formulations to overcome them rapidly. We use in house technologies to understand each compound to identify the potential issues which may arise and develop strategies to overcome unique challenges. formufastTM allows rapid, tailored screening of small quantities of API against a range of excipients. Using our experience and knowledge these are chosen depending on the requirements of the drug compound and screened to find the most suitable formulation. formufastTM for Early Enabling formulations. We understand that working with different compounds requires a tailored approach, so formufastTM is designed to develop a range of different formulation approaches from size reduction, aqueous solutions, solid dispersion and lipid formulations for oral administration as well as parenteral solutions. Additionally we can use our in vitro analysis methods to examine potential formulations effects in vivo with minimal material usage. Advantages of formufastTM screening include: Rapid identification of potential bioavailability issues Tailored approaches to overcome specific compound challenges Rational formulation approaches to achieve optimal outcomes In depth understanding of formulation effects and in vivo prediction Contact Us Stay up-to-date with the latest from Almac Join our mailing list Contact Us Complete the form below and we will be in touch shortly… Confirm you have read and accepted the Almac Privacy Policy *By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to info@almacgroup.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list. Quick links Careers About Us Our Locations Latest News Knowledge Centre Almac Discovery Almac Diagnostic Services Privacy Policy Galen Pharmaceuticals Get in touch European Enquiries: +44 (0) 28 3833 2200 North American Enquiries: +1 (215) 660 8500 Asia Pacific Enquiries: +65 6309 0720 Social links linkedin twitter youtube vimeo One way biotechs can reduce risk & promote optimised supply chains is by embracing a demand led, Just in Time Manuf… twitter.com/i/web/status/1… 5 mins ago ©2021 Almac Group Company Information Terms and Conditions Privacy & Cookie Policy Modern Slavery Statement By continuing to browse the site, you are agreeing to our use of cookies Agree